Trials / Conditions / Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Acute Myeloid Leukemia With Myelodysplasia-Related Changes
7 registered clinical trials studyying Acute Myeloid Leukemia With Myelodysplasia-Related Changes — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | VYxeoS Liposomal Italian Observational Study iN the Real Practice NCT06143839 | Jazz Pharmaceuticals | — |
| Active Not Recruiting | CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old NCT04269213 | Roswell Park Cancer Institute | Phase 2 |
| Active Not Recruiting | CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-relat NCT04231851 | University of California, Irvine | Phase 2 |
| Completed | A Post-Marketing Observational Study of VYXEOS™ NCT03526926 | Jazz Pharmaceuticals | — |
| Active Not Recruiting | Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia NCT03330821 | University of Southern California | Phase 1 / Phase 2 |
| Recruiting | Personalized NK Cell Therapy in CBT NCT02727803 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute NCT00416598 | National Cancer Institute (NCI) | Phase 2 |